M
Marcia J. Kayath
Researcher at Eli Lilly and Company
Publications - 5
Citations - 119
Marcia J. Kayath is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Insulin lispro & Insulin. The author has an hindex of 3, co-authored 5 publications receiving 111 citations. Previous affiliations of Marcia J. Kayath include Federal University of São Paulo.
Papers
More filters
Journal ArticleDOI
A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units
Ana M. C. Sogayar,Flávia Ribeiro Machado,Álvaro Réa-Neto,Amselmo Dornas,Cintia Magalhães Carvalho Grion,Suzana Margareth Lobo,Bernardo R. Tura,Carla Lika de Oliveira Silva,Ruy Guilherme Rodrigues Cal,Idal Beer,Vilto Michels,Jorge Safi,Marcia J. Kayath,Eliezer Silva +13 more
TL;DR: The present study provides the first economic analysis of direct costs of sepsis in Brazilian ICUs and reveals that the cost of Sepsis treatment is high.
Journal ArticleDOI
Revisão da hiperglicemia pós-prandial e a hipoglicemia no controle do diabetes mellitus: o papel da insulina lispro e suas pré-misturas nos picos e vales
TL;DR: The clinical profile of a rapid-acting human insulin analogue, insulin lispro, and of a new long-acting analog insulin lISpro NPL and fixed mixtures of insulin l ispro and NPL (insulin lis Pro Mix25 and insulin l Ispro Mix50) are revised.
Journal ArticleDOI
Raloxifeno e osteoporose: revisão de um novo modulador seletivo do receptor de estrógeno
TL;DR: Raloxifeno e uma alternativa para o tratamento e prevencao de osteoporose em mulheres na pos-menopausa com evidencias de efeitos beneficos seletivos em outros orgaos.
Journal ArticleDOI
Menor incidência de hipoglicemia noturna com o uso de insulina lispro comparada à insulina humana regular no tratamento de pacientes com diabetes do tipo 1
Bernardo Léo Wajchenberg,Antonio Roberto Chacra,Adriana Costa e Forti,Sandra Roberta Gouvea Ferreira,Odette de Oliveira,Carla Andréa Facury Lopes,Antonio C. Lerário,Rita de Cássia Sena,Marcia J. Kayath +8 more
TL;DR: Insulin lispro was a safe and efficacious option, with lower incidence of nocturnal hypoglycemia in type 1 diabetics, in a crossover, multicenter, randomized trial in 25 type 1 diabetic patients in use of human NPH and regular insulin.
Journal ArticleDOI
Aceitabilidade e funcionalidade de uma nova caneta para administração de insulina (Humapen®): experiência clínica em pacientes brasileiros
José Egídio Paulo de Oliveira,Adolpho Milech,Mariangélica Oliveira da Silva,Leão Zagury,Ivan S. Ferraz,Ana Lúcia C. Correia,Edgard D'Avila Niclewicz,Rosangela S. Ataide,Fadlo Fraige Filho,Paula Pascalli,Eucy Falcão,Marcia J. Kayath +11 more
TL;DR: The use of an insulin pen should be considered in diabetic patients, in patients with fixed mixtures, basal intermediate insulin, and especially in multiple injections regimens.